DISCLOSURE AS PER SEBI SAST REG 29(1) REG 2011

NIMIT RAJESH GHATALIA B1501/2, Highland Park, Lion Sol Marg, Lokhandwala Complex, Andheri West, Mumbai 400053 01-10-2026 To, To, To, NATIONAL STOCK EXCHANGE BSE LIMITED AAREY DRUGS & LIMITED PHARMACEUTICALS Exchange Plaza, C -1, Block G, Phiroze Jeejeebhoy E 34, MIDC, Tarapur, Bandra Kurla Complex, Towers Boisar, Thane, Bandra (E) Dalal Street Maharashtra, 401506 Mumbai – 400 051 Mumbai- 400001 Sub: Intimation/Disclosures under Reg. 29(1) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 . Dear Sir, With reference to the provisions of R egulation 29(1) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 and the amendments made therein, I, NIMIT RAJESH GHATALIA wish to inform that pursuant to conversion of Warrants I have been allotted 1,50,000 Equity Shares in the Board Meeting held on 30 -09-2026 after the said allotment my post allotment holding is 16,50,000 (5.18%) Equity Shares of AAREY DRUGS & PHARMACEUTICALS LTD (“The Company”). Please find enclosed herewith the relevant information in th e prescribed Format . I request you to kindly take the above information on your record. Thanking you, Yours sincerely NIMIT RAJESH GHATALIA Encl.: As Above FORMAT FOR DISCLOSURES UNDER REGULATION 29(1) OF SEBI (SUBSTANTIAL ACQUISITION OF SHARES AND TAKEOVERS) REGULATIONS, 2011 Part-A- Details of the Acquisition Name of the Target Company (TC) Aarey Drugs & Pharmaceuticals Ltd Name(s) of the acquirer and Persons Acting in YES Concert (PAC) with the acquirer Whether the acquirer belongs to Promoter/Promoter NYOES group Name(s) of the Stock Exchange(s) where the shares 1. BSE (INDIA) LIMITED of TC are Listed 2. NATIONAL STOCK EXCHANGE OF (I) LIMITED Details of the acquisition as follows Number % w.r.t. total % w.r.t total share/voting diluted capital wherever share/voting applicable(*) capital of the TC (**) Before the acquisition under consideration, holding of acquirer along with PACs of: a) Shares carrying voting rights 1500000 4.88% 4.49% b) Shares in the nature of encumbrance Nil N.A. N.A. (pledge/ lien/ non-disposal undertaking/ others) c) Voting rights (VR) otherwise than by equity Nil N.A. N.A. shares d) Warrants/convertible securities/any other 150000 0.49% 0.45% instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) e) Total (a+b+c+d) 1650000 -- -- Details of acquisition a) Shares carrying voting rights acquired 150000 0.47% 0.45% b) VRs acquired otherwise than by equity shares Nil N.A. N.A. c) Warrants/convertible securities/any other instrument that entitles the acquirer to Nil N.A. N.A. receive shares carrying voting rights in the TC (specify holding in each category) acquired d) Shares in the nature of encumbrance (pledge/ lien/ non-disposal undertaking/ Nil N.A. N.A. others) e) Total (a+b+c+/-d) 150000 0.47% 0.45% After the acquisition, holding of acquirer along with PACs of: a) Shares carrying voting rights 1650000 5.18% 4.94% b) VRs otherwise than by equity shares Nil N.A. N.A. c) Warrants/convertible securities/any other Nil N.A. N.A. instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) after acquisition d) Shares in the nature of encumbrance Nil N.A. N.A. (pledge/ lien/ non-disposal undertaking/ others) 1650000 5.18% 4.94% e) Total (a+b+c+d) Mode of acquisition (e.g. open market / public issue ALLOTMENT PURSUANT TO CONVERSION OF / rights issue / preferential allotment / inter-se WARRANTS transfer/encumbrance, etc.) Salient features of the securities acquired including time till redemption, ratio at which it can be Not Applicable converted into equity shares, etc. Date of acquisition of/ date of receipt of intimation of allotment of shares / VR/ warrants/convertible 30-09-2026 securities/any other instrument that entitles the acquirer to receive shares in the TC. Equity share capital / total voting capital of the TC 30724303 Equity Shares of Rs. 10/- Each before the said acquisition Equity share capital/ total voting capital of the TC 31874303 Equity Shares of Rs. 10/- Each after the said acquisition Total diluted share/voting capital of the TC after the 33354303 Equity Shares of Rs. 10/- Each said acquisition Part-B*** Name of the Target Company: Aarey Drugs & Pharmaceuticals Ltd Name(s) of the Acquirer and Whether the acquirer belongs PAN of the Acquirer and/or Person Acting in Concert (PAC) to Promoter/Promoter Group PACs with the Acquirer NIMIT RAJESH GHATALIA YES BBCPG4901J NIMIT RAJESH GHATALIA NAME OF THE ACQUIRER SIGNATURE